News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
663,510 Results
Type
Article (33428)
Company Profile (719)
Press Release (629360)
Multimedia
Podcasts (88)
Webinars (19)
Section
Business (196986)
Career Advice (2126)
Deals (36224)
Drug Delivery (113)
Drug Development (77818)
Employer Resources (165)
FDA (15355)
Job Trends (14694)
News (332013)
Policy (28693)
Tag
Academia (1262)
Academic (1)
Accelerated approval (20)
Adcomms (22)
Allergies (122)
Alliances (46829)
ALS (154)
Alzheimer's disease (1528)
Antibody-drug conjugate (ADC) (263)
Approvals (15479)
Artificial intelligence (452)
Autoimmune disease (118)
Automation (28)
Bankruptcy (376)
Best Places to Work (10834)
BIOSECURE Act (23)
Biosimilars (161)
Biotechnology (442)
Bladder cancer (128)
Brain cancer (47)
Breast cancer (474)
Cancer (4000)
Cardiovascular disease (346)
Career advice (1772)
Career pathing (37)
CAR-T (256)
CDC (20)
Cell therapy (683)
Cervical cancer (30)
Clinical research (66400)
Collaboration (1450)
Company closure (4)
Compensation (1012)
Complete response letters (61)
COVID-19 (2265)
CRISPR (80)
C-suite (699)
Cystic fibrosis (135)
Data (5272)
Decentralized trials (2)
Denatured (8)
Depression (115)
Diabetes (412)
Diagnostics (6505)
Digital health (37)
Diversity (5)
Diversity, equity & inclusion (38)
Drug discovery (206)
Drug pricing (173)
Drug shortages (27)
Duchenne muscular dystrophy (201)
Earnings (86101)
Editorial (47)
Employer branding (24)
Employer resources (145)
Events (113408)
Executive appointments (971)
FDA (17921)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (1279)
Gene editing (182)
Generative AI (41)
Gene therapy (529)
GLP-1 (917)
Government (3014)
Grass and pollen (8)
Guidances (367)
Healthcare (15873)
HIV (44)
Huntington's disease (42)
IgA nephropathy (76)
Immunology and inflammation (242)
Immuno-oncology (28)
Indications (67)
Infectious disease (2496)
Inflammatory bowel disease (175)
Inflation Reduction Act (12)
Influenza (97)
Intellectual property (208)
Interviews (429)
IPO (17303)
IRA (49)
Job creations (4223)
Job search strategy (1452)
Kidney cancer (14)
Labor market (76)
Layoffs (623)
Leadership (32)
Legal (7142)
Liver cancer (84)
Longevity (12)
Lung cancer (556)
Lymphoma (312)
Machine learning (34)
Management (60)
Manufacturing (662)
MASH (153)
Medical device (13787)
Medtech (13824)
Mergers & acquisitions (19870)
Metabolic disorders (1095)
Multiple sclerosis (139)
NASH (19)
Neurodegenerative disease (275)
Neuropsychiatric disorders (75)
Neuroscience (2602)
NextGen: Class of 2025 (5980)
Non-profit (1917)
Now hiring (61)
Obesity (516)
Opinion (284)
Ovarian cancer (134)
Pain (166)
Pancreatic cancer (186)
Parkinson's disease (242)
Partnered (29)
Patents (439)
Patient recruitment (374)
Peanut (55)
People (57830)
Pharmaceutical (134)
Pharmacy benefit managers (25)
Phase I (20921)
Phase II (29683)
Phase III (21928)
Pipeline (3522)
Policy (246)
Postmarket research (1909)
Preclinical (8473)
Press Release (64)
Prostate cancer (206)
Psychedelics (48)
Radiopharmaceuticals (274)
Rare diseases (699)
Real estate (5723)
Recruiting (69)
Regulatory (22066)
Reports (40)
Research institute (1355)
Resumes & cover letters (332)
Rett syndrome (20)
RNA editing (13)
RSV (71)
Schizophrenia (137)
Series A (222)
Series B (172)
Service/supplier (26)
Sickle cell disease (89)
Special edition (24)
Spinal muscular atrophy (151)
Sponsored (28)
Startups (3904)
State (2)
Stomach cancer (16)
Supply chain (93)
Tariffs (93)
The Weekly (79)
Vaccines (871)
Venture capital (75)
Weight loss (349)
Women's health (53)
Worklife (20)
Date
Today (179)
Last 7 days (677)
Last 30 days (2607)
Last 365 days (30533)
2025 (29040)
2024 (35515)
2023 (40248)
2022 (50369)
2021 (53519)
2020 (50519)
2019 (41710)
2018 (31895)
2017 (32336)
2016 (30457)
2015 (35846)
2014 (28506)
2013 (23511)
2012 (25083)
2011 (25262)
2010 (23127)
Location
Africa (678)
Alabama (82)
Alaska (6)
Arizona (209)
Arkansas (11)
Asia (40863)
Australia (6663)
California (10245)
Canada (2995)
China (971)
Colorado (422)
Connecticut (449)
Delaware (283)
Europe (89703)
Florida (1483)
Georgia (316)
Hawaii (3)
Idaho (58)
Illinois (665)
India (58)
Indiana (494)
Iowa (21)
Japan (326)
Kansas (118)
Kentucky (36)
Louisiana (22)
Maine (75)
Maryland (1140)
Massachusetts (7621)
Michigan (308)
Minnesota (579)
Mississippi (4)
Missouri (119)
Montana (32)
Nebraska (23)
Nevada (109)
New Hampshire (77)
New Jersey (2773)
New Mexico (30)
New York (2675)
North Carolina (1429)
North Dakota (8)
Northern California (4890)
Ohio (278)
Oklahoma (17)
Oregon (44)
Pennsylvania (2058)
Puerto Rico (19)
Rhode Island (45)
South America (1059)
South Carolina (57)
South Dakota (1)
Southern California (3882)
Tennessee (129)
Texas (1537)
United States (36346)
Utah (291)
Vermont (1)
Virginia (234)
Washington D.C. (73)
Washington State (845)
West Virginia (4)
Wisconsin (87)
Wyoming (2)
663,510 Results for "bristol myers squibb company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb to Host Hematology-Focused Investor Event
November 24, 2025
·
1 min read
Press Releases
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
November 27, 2025
·
1 min read
Press Releases
Terray Therapeutics Achieves AI-Enabled Drug Discovery Milestone in Collaboration with Bristol Myers Squibb
Success demonstrates the power of EMMI, Terray’s proprietary AI platform integrated with its rapidly expanding 13B+ target-ligand binding database and highly automated lab
December 4, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Prices €5 Billion of Senior Unsecured Notes
November 5, 2025
·
5 min read
Press Releases
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers
November 19, 2025
·
11 min read
Press Releases
Bristol Myers Squibb Reports Third Quarter Financial Results for 2025
October 30, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer’s Disease
December 3, 2025
·
4 min read
Press Releases
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
October 27, 2025
·
3 min read
Press Releases
Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
November 3, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio
December 2, 2025
·
19 min read
1 of 66,351
Next
